Drug firm confident as profits rise
United has also announced a 6.4 for 1 share split in a move to make the stock more attractive to ordinary investors. On the back of the good results, which showed sales and profits up 18% and 22% respectively the shares rose 10c or 1% in early trading in Dublin to €13.70.
During the period, revenues rose 1% to €561.4m from €475.5m. Interim pre-tax profits rose 23% to over €16m, while trading profit was 22% higher at €17.7m. Adjusted earnings per share rose 16% to 43.5c, in line with forecasts.
